These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 38009019)

  • 41. Tumor cell-specific AIM2 regulates growth and invasion of cutaneous squamous cell carcinoma.
    Farshchian M; Nissinen L; Siljamäki E; Riihilä P; Piipponen M; Kivisaari A; Kallajoki M; Grénman R; Peltonen J; Peltonen S; Quint KD; Bavinck JNB; Kähäri VM
    Oncotarget; 2017 Jul; 8(28):45825-45836. PubMed ID: 28526809
    [TBL] [Abstract][Full Text] [Related]  

  • 42. MicroRNA-135b Regulates Leucine Zipper Tumor Suppressor 1 in Cutaneous Squamous Cell Carcinoma.
    Olasz EB; Seline LN; Schock AM; Duncan NE; Lopez A; Lazar J; Flister MJ; Lu Y; Liu P; Sokumbi O; Harwood CA; Proby CM; Neuburg M; Lazarova Z
    PLoS One; 2015; 10(5):e0125412. PubMed ID: 25938461
    [TBL] [Abstract][Full Text] [Related]  

  • 43. MicroRNA-31 is overexpressed in cutaneous squamous cell carcinoma and regulates cell motility and colony formation ability of tumor cells.
    Wang A; Landén NX; Meisgen F; Lohcharoenkal W; Ståhle M; Sonkoly E; Pivarcsi A
    PLoS One; 2014; 9(7):e103206. PubMed ID: 25068518
    [TBL] [Abstract][Full Text] [Related]  

  • 44. UBE2C promotes rectal carcinoma via miR-381.
    Zhang Y; Tian S; Li X; Ji Y; Wang Z; Liu C
    Cancer Biol Ther; 2018 Mar; 19(3):230-238. PubMed ID: 29303411
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Aberrant expression of B7-H4 and B7-H5 contributes to the development of cutaneous squamous cell carcinoma.
    Chen L; Zhou B; Tang M; Yao Y; Zhao Y; Hu Y; Lin Y; Ji J; Jiao Q
    Arch Dermatol Res; 2024 Jun; 316(7):382. PubMed ID: 38850312
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Overexpression of UBE2C in esophageal squamous cell carcinoma tissues and molecular analysis.
    Li R; Pang XF; Huang ZG; Yang LH; Peng ZG; Ma J; He RQ
    BMC Cancer; 2021 Sep; 21(1):996. PubMed ID: 34488675
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Long non-coding RNA PICSAR knockdown inhibits the progression of cutaneous squamous cell carcinoma by regulating miR-125b/YAP1 axis.
    Lu X; Gan Q; Gan C; Zheng Y; Cai B; Li X; Li D; Yin G
    Life Sci; 2021 Jun; 274():118303. PubMed ID: 32841663
    [TBL] [Abstract][Full Text] [Related]  

  • 48. KLF9 (Kruppel Like Factor 9) induced PFKFB3 (6-Phosphofructo-2-Kinase/Fructose-2, 6-Biphosphatase 3) downregulation inhibits the proliferation, metastasis and aerobic glycolysis of cutaneous squamous cell carcinoma cells.
    Xing J; Jia Z; Xu Y; Chen M; Yang Z; Chen Y; Han Y
    Bioengineered; 2021 Dec; 12(1):7563-7576. PubMed ID: 34612136
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Pan-Cancer Analyses of the Tumor Microenvironment Reveal That Ubiquitin-Conjugating Enzyme E2C Might Be a Potential Immunotherapy Target.
    Huang GZ; Chen ZQ; Wu J; Shao TR; Zou C; Ai YL; Lv XZ
    J Immunol Res; 2021; 2021():9250207. PubMed ID: 34950739
    [TBL] [Abstract][Full Text] [Related]  

  • 50. UBE2C Drives Human Cervical Cancer Progression and Is Positively Modulated by mTOR.
    Chiang AJ; Li CJ; Tsui KH; Chang C; Chang YI; Chen LW; Chang TH; Sheu JJ
    Biomolecules; 2020 Dec; 11(1):. PubMed ID: 33396624
    [TBL] [Abstract][Full Text] [Related]  

  • 51. MMP1 regulated by NEAT1/miR-361-5p axis facilitates the proliferation and migration of cutaneous squamous cell carcinoma via the activation of Wnt pathway.
    Jiang S; Liu H; Zhang J; Zhang F; Fan J; Liu Y
    Cancer Biol Ther; 2021 Jun; 22(5-6):381-391. PubMed ID: 34369270
    [TBL] [Abstract][Full Text] [Related]  

  • 52. MicroRNA-664 functions as an oncogene in cutaneous squamous cell carcinomas (cSCC) via suppressing interferon regulatory factor 2.
    Li X; Zhou C; Zhang C; Xie X; Zhou Z; Zhou M; Chen L; Ding Z
    J Dermatol Sci; 2019 Jun; 94(3):330-338. PubMed ID: 31138473
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Alterations of microRNAs throughout the malignant evolution of cutaneous squamous cell carcinoma: the role of miR-497 in epithelial to mesenchymal transition of keratinocytes.
    Mizrahi A; Barzilai A; Gur-Wahnon D; Ben-Dov IZ; Glassberg S; Meningher T; Elharar E; Masalha M; Jacob-Hirsch J; Tabibian-Keissar H; Barshack I; Roszik J; Leibowitz-Amit R; Sidi Y; Avni D
    Oncogene; 2018 Jan; 37(2):218-230. PubMed ID: 28925390
    [TBL] [Abstract][Full Text] [Related]  

  • 54. NR5A2 promotes malignancy progression and mediates the effect of cisplatin in cutaneous squamous cell carcinoma.
    Ye W; Ya-Xuan C; Shan-Shan T; Qiu L; Ting M; Shao-Jie C; Yu C
    Immun Inflamm Dis; 2024 Feb; 12(2):e1172. PubMed ID: 38358044
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Ubiquitin-conjugating enzyme E2C regulates apoptosis-dependent tumor progression of non-small cell lung cancer via ERK pathway.
    Zhang Z; Liu P; Wang J; Gong T; Zhang F; Ma J; Han N
    Med Oncol; 2015 May; 32(5):149. PubMed ID: 25832867
    [TBL] [Abstract][Full Text] [Related]  

  • 56. MiR-1193 was sponged by LINC00963 and inhibited cutaneous squamous cell carcinoma progression by targeting SOX4.
    Wang J; Li C; Xu L; Yang C; Zhang X
    Pathol Res Pract; 2019 Oct; 215(10):152600. PubMed ID: 31477326
    [TBL] [Abstract][Full Text] [Related]  

  • 57. GRIM-19 represses the proliferation and invasion of cutaneous squamous cell carcinoma cells associated with downregulation of STAT3 signaling.
    Wu N; Hui H; Cui L; Yang F
    Biomed Pharmacother; 2017 Nov; 95():1169-1176. PubMed ID: 28926927
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Downregulation of ARMC8 promotes tumorigenesis through activating Wnt/β-catenin pathway and EMT in cutaneous squamous cell carcinomas.
    Li X; Zhang C; Yuan Y; Wang Y; Lu S; Zhou Z; Zhen P; Zhou M
    J Dermatol Sci; 2021 Jun; 102(3):184-192. PubMed ID: 34016486
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Pre-mRNA processing factor 3 enhances the progression of keratinocyte-derived cutaneous squamous cell carcinoma by regulating the JAK2/STAT3 pathway.
    Zuo S; Li X; Bao W; Li S
    Sci Rep; 2020 Jun; 10(1):8863. PubMed ID: 32483193
    [TBL] [Abstract][Full Text] [Related]  

  • 60. miR-497 promotes the progression of cutaneous squamous cell carcinoma through FAM114A2.
    Wei XH; Gu XL; Zhou XT; Ma M; Lou CX
    Eur Rev Med Pharmacol Sci; 2018 Nov; 22(21):7348-7355. PubMed ID: 30468480
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.